Aniline CompoundsAntineoplastic AgentsApoptosis
Dr. Naoko Takebe, MD, PhD
NPI1265473045PAC ID4385165182
- Publications
- 112
- Clinical trials
- 8
- Hospital affiliations
- 1
- Industry payments
- $673
- Medical group
- 1
- Practice address
- 1200 Childrens Ave, Oklahoma City, OK 73104
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Ou Medical Center-The Children's Ho - Rad CT - HOPD
Acute Care Hospital outpatient department · Oklahoma City, Oklahoma
Find Dr. Takebe's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Naoko Takebe is a hematologist and oncologist in Oklahoma City, Oklahoma
Dr. Takebe practices at Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma.
Dr. Takebe's NPI, 1265473045, was assigned on June 10, 2006. Dr. Takebe holds Maryland license D55341.
NPI and contact details
- NPI
- 1265473045NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4385165182
- NPI enumeration date
- June 10, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 50
- Medical school graduation
- 2002
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Naoko Takebe practices at Ou Medical Center-the Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma
Dr. Takebe's primary practice is Ou Medical Center-the Children's Ho - Rad CT - HOPD, at 1200 Childrens Ave, Oklahoma City, OK 73104.
- Ou Medical Center-the Children's Ho - Rad CT - HOPD1200 Childrens Ave, Oklahoma City, OK 73104
Source: Dmand AI Affiliation Data
Dr. Naoko Takebe is affiliated with 3 sites of care and 1 medical group
Dr. Takebe's primary practice is Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma. Dr. Takebe is also affiliated with OU Health University of Oklahoma Medical Center. The medical group on file is OU Health. Dmand AI also links Dr. Takebe to 1 more group practice or clinic, named with a free account.
Ou Medical Center-The Children's Ho - Rad CT - HOPDPrimary
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Naoko Takebe's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Takebe practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Ou Medical Center-The Children's Ho - Rad CT - HOPD | Available with a free account |
| +2 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Takebe practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Naoko Takebe is one of 134 hematologists and oncologists in Oklahoma
Hematology and oncology is Dr. Takebe's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Takebe is licensed in Maryland.
Specialties and state licenses
- Hematology and oncology, MarylandPrimary
Hematologists and oncologists near Dr. Takebe
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Naoko Takebe's patients have a median age of 70
Across all payers, Dmand AI patient panel data puts Dr. Takebe's median patient age at 70, with 65% women.
Dr. Takebe's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women65%
- Men35%
Source: Dmand AI Patient Panel Data
How Dr. Naoko Takebe takes part in Medicare
Dr. Takebe accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
Dr. Naoko Takebe has 112 publications on record
Dmand AI links 112 papers to Dr. Takebe, published from 2010 to 2025. 2021 was the busiest year, with 8. The most frequent topics are Antineoplastic Agents, Molecular Targeted Therapy and National Cancer Institute (U.S.). Dr. Takebe has published most often in Clin Cancer Res. Dr. Takebe's most frequent co-authors are Alice Chen, DO, Donald Williams Parsons, MD, PhD and Nita L. Seibel, MD.
Papers112
Years published2010 to 2025
Dr. Takebe's papers by year, 2016 to 2025
Topics Dr. Takebe writes about most
- Antineoplastic Agents
- Molecular Targeted Therapy
- National Cancer Institute (U.S.)
- Precision Medicine
- Cell Line, Tumor
- Antineoplastic Combined Chemotherapy Protocols
- Signal Transduction
- Biomarkers, Tumor
Dr. Takebe's most frequent co-authors
- Alice Chen, DO18 shared papers
- Donald Williams Parsons, MD, PhD9 shared papers
- Nita L. Seibel, MD9 shared papers
Recent publications by Dr. Takebe
Cancer Chemother Pharmacol
Aniline CompoundsAntineoplastic Combined Chemotherapy ProtocolsBenzamides
Antineoplastic AgentsCell Line, TumorDrug Screening Assays, Antitumor
BenzamidesNeurofibromin 2Pyrazines
See who Dr. Takebe researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Takebe works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Naoko Takebe has worked on 8 clinical trials
Dmand AI links Dr. Takebe to 8 clinical trials, 6 of them phase 1 studies. 5 are still active or recruiting. Conditions studied include Neoplasm Metastasis, Cystadenocarcinoma, Mucinous and Desmoid Tumors. National Cancer Institute (NCI) sponsors the most, 8.
Clinical trials with Dr. Takebe by phase
- 6Phase 1: 6 trials
- 2Phase 2: 2 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Takebe's trials
- Neoplasm Metastasis
- Cystadenocarcinoma, Mucinous
- Desmoid Tumors
- Liver Diseases
- Myelodysplastic Syndromes
Investigators on the most trials with Dr. Takebe
- Mitchell B. Alden, DO1 shared trial
- Haythem Y. Ali, MD1 shared trial
- Leonard Joseph Appleman, MD1 shared trial
Recent clinical trials with Dr. Takebe
Phase I Trial of Z-Endoxifen in Adults With Refractory Hormone Receptor-Positive Breast Cancer, Desmoid Tumors, Gynecologic Tumors, or Other Hormone Receptor-Positive Solid Tumors (opens in a new tab)
Active, not recruitingPhase 1
Desmoid TumorsFibromaZ-Endoxifen
Myelodysplastic SyndromesBone Marrow DiseasesBortezomib plus Clofarabine
A Phase 1 Trial of the ATR Inhibitor BAY 1895344 in Combination With Cisplatin and With Cisplatin Plus Gemcitabine in Advanced Solid Tumors With an Emphasis on Urothelial Carcinoma (opens in a new tab)
Active, not recruitingPhase 1
Penile NeoplasmsPenile DiseasesCisplatinElimusertibGemcitabine Hydrochloride
A Phase I Study of AZD8186 in Combination With Docetaxel in Patients With PTEN Mutated or PIK3CB Mutated Advanced Solid Tumors, Potentially Amenable to Docetaxel (opens in a new tab)
Active, not recruitingPhase 1
Triple Negative Breast NeoplasmsNeoplasm MetastasisDocetaxelPI3Kbeta Inhibitor AZD8186
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Naoko Takebe received $673 in industry payments from 2017 to 2025
CMS Open Payments shows 10 general payments to Dr. Takebe from 4 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $394.
General payments to Dr. Takebe by program year, 2017 to 2025
Companies that paid Dr. Takebe the most, 2017 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Naoko Takebe's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Naoko Takebe
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Naoko Takebe's NPI number?
Dr. Naoko Takebe's NPI number is 1265473045. It was assigned on June 10, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Naoko Takebe?
Dr. Naoko Takebe is a hematologist and oncologist in Oklahoma City, Oklahoma. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Naoko Takebe practice?
Dr. Takebe practices at 1200 Childrens Ave, Oklahoma City, OK 73104. Dr. Takebe's primary practice is Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma. Dmand AI also links Dr. Takebe to 1 group practice or clinic.
What is Dr. Naoko Takebe's medical license number?
Dr. Takebe holds Maryland license D55341.
Which hospitals is Dr. Naoko Takebe affiliated with?
Dr. Takebe is affiliated with OU Health University of Oklahoma Medical Center.
What medical group is Dr. Naoko Takebe part of?
Dr. Takebe is linked to OU Health.
Does Dr. Naoko Takebe accept Medicare?
Yes. CMS lists Dr. Takebe as accepting Medicare assignment.
Has Dr. Naoko Takebe received payments from drug or device companies?
CMS Open Payments shows $673 in general payments to Dr. Takebe from 4 companies from 2017 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Naoko Takebe been practicing?
Dr. Takebe graduated from medical school in 2002, 24 years ago.
Does Dr. Naoko Takebe do research?
Dmand AI links 112 publications to Dr. Takebe, published from 2010 to 2025. Dr. Takebe has worked on 8 clinical trials.
Who does Dr. Naoko Takebe publish with?
Dr. Takebe's most frequent co-authors are Alice Chen, DO (18 shared papers), Donald Williams Parsons, MD, PhD (9 shared papers) and Nita L. Seibel, MD (9 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Oklahoma by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card